Representative before the EPO

Company dna page white and farrer
no operation time available
2 offices
active in Legal Services

We have observed 27 EP applications Clare Jean Stephens has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12787022

NUCLEIC ACID PRODUCTION AND SEQUENCE ANALYSIS

IPC classification:
C12Q 1/68
Applicant:
Vilnius University (Vilniaus universitetas)
Agent:
Clare Jean Stephens, Page White & Farrer
Agent:
Jurga Petniunaite, AAA Law Patent & Trademark Attorney (AAA Patendibüroo OÜ)
Status:
PATENT GRANTED
EP12798723

USES OF IMMUNOCONJUGATES TARGETING CD138

IPC classification:
A61K 47/48, A61P 35/00
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP14170861

Agents targeting CD138 and uses thereof

IPC classification:
A61P 35/00, C07K 16/28, C07K 16/30
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP12825119

MULTI-COPY STRATEGY FOR HIGH-TITER AND HIGH-PURITY PRODUCTION OF MULTI-SUBUNIT PROTEINS SUCH AS A ANTIBODIES IN TRANSFORMED MICROBES SUCH AS PICHIA PASTORIS

IPC classification:
C07K 16/00, C12N 1/19, C12N 1/38, C12N 15/12, C12N 15/63, C12P 21/00, C12P 21/08
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP12788717

USE OF ANTI-CGRP OR ANTI-CGRP-R ANTIBODIES OR ANTIBODY FRAGMENTS TO TREAT OR PREVENT CHRONIC AND ACUTE FORMS OF DIARRHEA

IPC classification:
A61K 31/7088, A61K 38/16, A61K 39/00, A61K 39/395, A61K 45/06, A61K 48/00, A61P 1/12, C07K 16/26
Applicant:
University of Iowa Research Foundation
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP13784744

T CELL RECEPTOR-DEFICIENT T CELL COMPOSITIONS

IPC classification:
A61K 35/12, A61P 35/00, C12N 5/0783, C12N 5/10
Applicant:
Trustees of Dartmouth College
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP13787331

ANTI-PCSK9 ANTIBODIES AND USE THEREOF

IPC classification:
A61K 39/395, A61P 3/00, C07K 16/18, C07K 16/42
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP13784566

GENE EXPRESSION SIGNATURE FOR IL-6/STAT3 SIGNALING PATHWAY AND USE THEREOF

IPC classification:
C12N 15/11, C12Q 1/68, G01N 33/53
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP13787935

ANTI-B7-H6 ANTIBODY, FUSION PROTEINS, AND METHODS OF USING THE SAME

IPC classification:
C07K 16/28
Applicant:
Trustees of Dartmouth College
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP13806673

NOVEL VISTA-IG CONSTRUCTS AND THE USE OF VISTA-IG FOR TREATMENT OF AUTOIMMUNE, ALLERGIC AND INFLAMMATORY DISORDERS

IPC classification:
A61K 39/00, A61P 35/00, A61P 37/00, C07K 14/47, C07K 19/00
Applicant:
Trustees of Dartmouth College
Applicant:
King's College London
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP13834707

VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER

IPC classification:
A61K 39/395, A61K 48/00, A61P 35/00
Applicant:
Trustees of Dartmouth College
Applicant:
King's College London
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP14151373

Method for preparing a flame retardant modified acrylonitrile-based copolymer and a flame retardant fibrous material

IPC classification:
C08F 20/44, C08F 220/44, D01F 6/18, D01F 6/38, D01F 9/22
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15248004

IMPROVED MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA

IPC classification:
C12N 5/0797
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP15248003

IMPROVED MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA

IPC classification:
A01N 63/00, A01N 65/00, A61K 35/12, A61K 35/44, A61K 48/00, C12N 5/079, C12N 5/0793
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP13869692

HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE FOR THE DIAGNOSIS AND TREATMENT OF COLON AND PANCREAS CANCER

IPC classification:
C07K 16/18, G01N 33/574
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP15164137

DERIVATION OF EMBRYONIC STEM CELLS

IPC classification:
C12N 5/00, C12N 5/02, C12N 5/073, C12N 5/0735, C12N 5/075, C12N 15/82, C12N 15/873
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP14764393

TEMPERATURE SHIFT FOR HIGH YIELD EXPRESSION OF POLYPEPTIDES IN YEAST AND OTHER TRANSFORMED CELLS

IPC classification:
C12N 1/16, C12N 1/19, C12P 21/00
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP14763076

ANTIBODY PURIFICATION AND PURITY MONITORING

IPC classification:
C12N 1/19
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP16163265

DNA POLYMERASE MUTANTS HAVING INCREASED THERMOSTABILITY AND PROCESSIVITY

IPC classification:
C12N 9/12, C12P 19/34, C12Q 1/68
Applicant:
Thermo Fisher Scientific Baltics UAB
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP16177660

PRODUCTION OF NUCLEIC ACID

IPC classification:
C12N 9/12, C12N 15/10
Applicant:
Thermo Fisher Scientific Baltics UAB
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
Request for examination was made
EP15748635

IMPROVED PROCESS FOR THE SYNTHESIS OF SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES

IPC classification:
A23F 5/40, A61K 31/422, A23L 27/20
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP15752472

ANTI-ACTH ANTIBODIES AND USE THEREOF

IPC classification:
A61K 39/00, C07K 16/00, C12P 21/08
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP15716147

MODIFIED ANTIBODIES CONTAINING MODIFIED IGG2 DOMAINS WHICH ELICIT AGONIST OR ANTAGONISTIC PROPERTIES AND USE THEREOF

IPC classification:
C07K 16/28
Applicant:
Cancer Research Technology Ltd
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP15796829

HIGH THROUGHPUT TELOMERIC CIRCLE ASSAY

IPC classification:
C12Q 1/68
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP15838895

COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF

IPC classification:
A61K 38/19, A61K 39/395, C07K 16/24, C12P 21/08
Applicant:
Boehringer Ingelheim International GmbH
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
Request for examination was made
EP15865129

IDENTIFICATION OF VSIG8 AS THE PUTATIVE VISTA RECEPTOR AND ITS USE THEREOF TO PRODUCE VISTA/VSIG8 MODULATORS

IPC classification:
A61K 38/16, A61K 39/395, C07K 16/46
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
Request for examination was made
EP16738007

ANTI-GLYCOPROTEIN ANTIBODIES AND USES THEREOF

IPC classification:
A01N 63/00, A01N 63/04, A61K 39/00, A61K 39/38, A61K 45/00, A61K 47/00
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
Request for examination was made

Please Sign in to use this feature